BPC-157 Purity: 4101 Lab Tests Across 1148 Identified Manufacturers
115 studies on BPC-157 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab currently tracks 4,101 published third-party lab tests of BPC-157 across 1,148 identified manufacturers. Among reports with a positive numeric purity result, the average is 99.14%. Within this published corpus, 18 positive purity results were below 90%, and 237 reports showed measured quantity more than 10% below the label claim. These are batch-level observations, not guarantees of product identity, safety, or vendor quality.
BPC-157 average prices
As of 2026-09-02, vendor-blind retail asking-price averages for the US delivery market, calculated from the same in-stock exact-strength cells as the Peptide Price Index. Shipping is excluded.
| Strength | Average / vial | Observed range / vial | Average / mg | Coverage |
|---|---|---|---|---|
| 5 mg | $7.50 | $5.50–$11.50 | $1.50 | 3 sources · 3 offers |
| 10 mg | $9.33 | $8.00–$10.50 | $0.93 | 6 sources · 6 offers |
| 20 mg | $14.75 | $14.50–$15.00 | $0.73 | 2 sources · 2 offers |
| 40 mg | $26.00 | $26.00–$26.00 | $0.65 | 1 source · 1 offer |
Asking prices are not manufacturing cost and do not establish product equivalence, quality, safety, or legality. The refresh date is the catalog build date; individual source observation dates are not available in this snapshot. View full price methodology →
We tested 4101 BPC-157 batches across 1148 identified manufacturers
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
Within that total, 843 batches have unresolved manufacturer identity. They remain in corpus-level lab evidence and are excluded from named-manufacturer rankings.
Top 3 vendor evidence profiles for BPC-157
Eligible vendors have at least 2 deduplicated tests and 2 classifiable identity observations. Rank uses the 95% lower confidence bound on clean identity results; mean positive purity and test count break ties. Missing measurements are not passes. Exact-zero/not-detected and explicit wrong-compound markers count once per adverse certificate. This describes tested batches, not every product or shipment, and is not an endorsement.
| Rank | Manufacturer | Tests | Avg positive purity | Identity adverse results | |
|---|---|---|---|---|---|
| #1 | 88 | 99.63% | 0 of 70 (0.0%) 0 0% / not detected · 0 wrong compound · 18 unclassified | Reveal with Pro → | |
| #2 | 42 | 99.32% | 0 of 38 (0.0%) 0 0% / not detected · 0 wrong compound · 4 unclassified | Reveal with Pro → | |
| #3 | 29 | 99.21% | 0 of 25 (0.0%) 0 0% / not detected · 0 wrong compound · 4 unclassified | Reveal with Pro → |
Manufacturer identities are included with Pro. Batch counts and lab measurements remain visible.
Recent certificates: #100809 (99.12%) · #100114 (99.36%) · #100398 (99.1%) · #100415 (99.87%) · #100432 (99.4%) · #100435 (99.12%)
BPC-157 studies and clinical research
-
BPC 157 therapy reverses severe vascular and multiorgan failure after unilateral adrenalectomy in rats
**BPC 157's profound ability to rapidly restore vascular integrity and organ function after severe systemic trauma, such as unilateral adrenalectomy, suggests broad utility in acute injury and circulatory compromise.*…
-
Harmonized LC-HRMS workflow detects 54 doping agents, including BPC-157 and TB500, in dried blood spots with enhanced stability.
This harmonized `LC-HRMS` workflow significantly advances **doping control capabilities**, offering a more efficient and cost-effective approach. The superior stability of many compounds, including key peptides like *…
-
BPC-157 and Novel Hybrid Analogs CIARA-1, CIARA-2 Competitively Inhibit Acetylcholinesterase
BPC-157 and its novel hybrid analogs, CIARA-1 and CIARA-2, competitively inhibit `Acetylcholinesterase (AChE)` in vitro, with CIARA-1 demonstrating the highest potency (Ki = **0.24 mM**).
-
Review: Thymosin Alpha-1, BPC-157 Show Emerging Promise for Thyroid Health, Immune Modulation
This review highlights that **peptide therapies could offer a crucial adjunctive strategy for managing persistent symptoms in autoimmune thyroid disorders like Hashimoto's thyroiditis**, moving beyond mere hormone rep…
-
Regenerative Medicine Strategies Offer Novel Hope for Refractory Craniofacial and Corneal Neuropathic Pain
**Regenerative medicine offers a transformative outlook for individuals suffering from severe craniofacial and corneal neuropathic pain that has proven refractory to conventional treatments.** This review suggests a f…
-
Review Identifies Major Biopharmaceutical and Translational Barriers for BPC-157 Development
This review underscores that despite extensive preclinical promise, **BPC-157** remains far from a clinically validated therapeutic. For peptide users and biohackers, this means current **BPC-157** preparations are la…
-
BPC-157 Faces Significant Biopharmaceutical and Regulatory Hurdles Hindering Clinical Translation
This comprehensive review underscores that current **BPC-157** use by biohackers and clinicians operates without validated protocols, approved formulations, or robust safety data. The identified `pharmacokinetic-pharm…
-
BPC 157 mitigates lower limb ischemia-reperfusion injury in rats by reducing oxidative stress and inflammation
These findings significantly bolster the evidence for **BPC 157 as a potent therapeutic agent for acute ischemia-reperfusion injury**, particularly in skeletal muscle. The ability of BPC 157 to simultaneously modulate…
-
BPC 157 induces endothelium-dependent vasorelaxation in human internal mammary arteries via nitric oxide.
This study provides the first direct evidence of BPC 157's endothelium-dependent vasorelaxant effects in human arterial tissue, a significant step beyond animal models. For peptide users and biohackers, this suggests …
-
Review Assesses Safety and Efficacy of Peptides for Muscle and Joint Injuries
-
Chemical Softening Agent Explored for Easier Esophageal Cancer Removal
If proven feasible and effective, the use of mesna solution could significantly simplify and improve the safety of Endoscopic Submucosal Dissection (ESD) for superficial oesophageal squamous neoplasms (SOSNs). This in…
-
BPC 157's Cytoprotective Role in Arrhythmias Alongside Conventional Therapies
-
BPC 157 and Growth Factors Show Promise for Musculoskeletal Injury Repair
This comprehensive review underscores the significant therapeutic potential of BPC 157 as a broad-spectrum regenerative agent for complex musculoskeletal injuries. Its unique cytoprotective mechanism, which includes s…
-
Lab Models Track Peptide Breakdown for Anti-Doping Tests
This research provides critical tools for anti-doping laboratories to predict and identify peptide metabolites, significantly improving detection windows for prohibited substances. By understanding the metabolic fate …
-
New In Vitro Models Improve Detection of Doping Peptide Metabolism
This research provides critical insights into the in vitro metabolic pathways of synthetic doping peptides, which is essential for developing robust and sensitive anti-doping tests. The identification of liver S9 frac…
-
BPC 157 Prevents Dangerous Drug-Induced Heart Rhythm Issues in Rats
This study powerfully demonstrates BPC 157's potential as a broad-spectrum cardioprotective agent against drug-induced QTc prolongation. Given the wide array of medications that can cause this adverse effect, BPC 157 …
-
BPC 157 and L-Arginine Protect Against Celecoxib's Multi-Organ Damage
-
BPC 157 Shows Potent Healing Effects in Rat Models of Colitis and Ischemia-Reperfusion
These compelling findings highlight BPC 157's significant therapeutic potential in treating severe gastrointestinal pathologies by promoting healing, reducing inflammation, and combating oxidative stress. Its ability …
-
BPC 157 Peptide Aids Vascular Repair and Reduces Thrombosis in Rats
This study provides compelling evidence that BPC 157 possesses significant anti-thrombotic and pro-angiogenic properties, making it a promising candidate for treating vascular disorders. The ability of BPC 157 to both…
-
BPC 157 Peptide Shows Promise Against Honeybee Parasite Nosema ceranae
This study provides compelling evidence that BPC 157 could represent a novel and highly effective therapeutic agent for combating Nosemosis in honeybees. The significant reduction in parasite load and improvement in c…
-
BPC 157 Boosts Gut Healing and Blood Vessel Growth
This study provides compelling evidence for the potent regenerative and cytoprotective effects of BPC 157, particularly its ability to promote vascular recruitment and accelerate gastrointestinal healing. The observed…
-
BPC157 Shows Promise in Combating Cancer Cachexia, Review Suggests
-
BPC-157 Promotes Broad Tissue Healing by Boosting Angiogenesis and Growth Factors
This comprehensive review unequivocally highlights BPC-157's broad therapeutic potential as a potent pro-angiogenic and regenerative agent. Its remarkable ability to promote and accelerate healing across such diverse …
-
Probiotic Bacteria Deliver BPC-157 Peptide for Enhanced Gut Antioxidant Effects
This study demonstrates a novel and effective strategy for targeted delivery of therapeutic peptides using engineered probiotics, potentially enhancing their efficacy in treating gut-related inflammatory conditions. T…
-
BPC 157 Protects Rat Gut from Strong Alcohol Damage via Nitric Oxide System
This research highlights BPC 157's potent ability to protect the gastrointestinal tract from severe alcohol-induced injury, suggesting it could be a valuable therapeutic agent. Its mechanism, involving the nitric oxid…
-
BPC 157 Peptide Shows Promise for Vascular Occlusion and Gut Lesions in Rats
-
BPC 157 Accelerates Healing of Severe Gut Injury in Rats
These results underscore the significant therapeutic potential of BPC 157 for severe gastrointestinal injuries, particularly those involving perforation and the risk of peritonitis and sepsis. The ability of BPC 157 t…
-
BPC 157 Shows Significant Promise in Treating Liver Damage from Bile Duct Ligation
This study powerfully demonstrates BPC 157's potent hepatoprotective, anti-inflammatory, and regenerative properties within a severe and clinically relevant model of liver injury. The ability of BPC 157 to significant…
-
BPC 157 Peptide Accelerates Soft Tissue Healing in Musculoskeletal Injuries
This research highlights that BPC 157 possesses potent regenerative properties that could dramatically improve outcomes for musculoskeletal injuries. Its ability to accelerate healing, enhance tissue strength, and red…
-
BPC 157: Reviewing Its Broad Protective Effects and Stress Response Modulation
This comprehensive review solidifies BPC 157's potential as a broad-spectrum therapeutic agent due to its consistent protective and reparative actions across diverse pathologies and organ systems. By linking its effec…
-
BPC 157 Peptide Shows Promise for Spinal Cord Injury Recovery in Rats
-
BPC 157 and L-Arginine Show Promise for Bladder Inflammation in Rats
This research highlights the significant therapeutic potential of BPC 157 and L-arginine as novel interventions for cyclophosphamide-induced hemorrhagic cystitis. The robust protective effects observed suggest these c…
-
BPC 157 Modulates Platelet Function and Blood Clotting with Antiplatelet Drugs
This research highlights a potentially transformative role for BPC 157 in improving the safety profile of widely used antiplatelet therapies. By mitigating the risk of excessive bleeding, BPC 157 could enable safer an…
-
BPC 157 Peptide Resolves Severe Liver Vein Occlusion in Rat Model
This study provides compelling evidence that BPC 157 could be a powerful therapeutic agent for conditions involving severe vascular occlusion and subsequent organ damage, such as Budd-Chiari syndrome. Its ability to p…
-
BPC 157 Peptide Shows Promise for Healing Complex Fistulas
The consistent and potent pro-healing effects of BPC 157 across multiple challenging fistula models highlight its significant potential as a novel therapeutic agent. This peptide could offer a non-invasive, effective …
-
BPC 157 Protects Gut from NSAID Damage by Stabilizing Permeability
These findings highlight BPC 157's significant potential as a therapeutic agent for preventing and treating NSAID-induced gastrointestinal damage. By simultaneously stabilizing intestinal permeability and enhancing in…
-
BPC 157 Peptide Resolves Liver Ischemia-Reperfusion Injury in Rats
This research highlights the significant therapeutic potential of BPC 157 for preventing or treating hepatic ischemia-reperfusion injury, a common and severe complication in liver surgery and transplantation. Given it…
-
BPC 157 Shows Promise for Brain Protection After Stroke-Like Injury
-
Stable Peptide BPC 157 Counteracts Lidocaine's Harmful Effects on Nerves
This research highlights BPC 157's significant potential as a protective agent against lidocaine-induced neurotoxicity, a substantial concern in various clinical settings where local anesthetics are used. The findings…
-
BPC 157 Reverses Schizophrenia-Like Catalepsy in Rat Models
This research highlights BPC 157's potential as a novel therapeutic agent for neurological conditions characterized by nitric oxide dysregulation, particularly those manifesting as schizophrenia-like symptoms or other…
-
BPC 157 Relaxes Blood Vessels by Activating Nitric Oxide Pathway
-
BPC 157 Peptide Significantly Reduces Post-Surgical Bowel Adhesions in Rats
This study provides compelling evidence that BPC 157 is a highly effective therapeutic agent for preventing and treating post-surgical bowel adhesions. The observed interaction with L-NAME and L-arginine strongly sugg…
-
BPC 157 Protects Against Clopidogrel-Induced Stomach Damage in Rats
This research highlights the significant gastroprotective potential of BPC 157 against drug-induced injury. The ability of BPC 157 to reduce lesion severity, inflammation, and oxidative stress while promoting healing …
-
BPC 157 Reverses Organ Dysfunction and Pressure Imbalances After Mesenteric Artery Occlusion
-
BPC 157 Accelerates Recovery from Corneal Anesthesia in Rats
This study unveils a novel therapeutic potential for BPC 157 beyond its well-established regenerative and protective properties, specifically in the context of modulating local anesthetic effects. Accelerating recover…
-
BPC 157 Protects Retina from Ischemic Damage in Rat Model
This study provides compelling evidence that BPC 157 possesses significant retinoprotective and neuroprotective properties against ischemia-induced damage. Its ability to preserve both retinal function and structural …
-
BPC 157 Promotes New Blood Vessel Growth After Brain Vein Blockage in Rats
The study revealed significant therapeutic effects of BPC 157 in mitigating the consequences of permanent superior sagittal sinus (SSS) occlusion. Animals treated with BPC 157 exhibited a marked improvement in neurolo…
-
BPC 157 Peptide Accelerates Wound Healing and Tissue Regeneration
These findings strongly underscore BPC 157's potent therapeutic potential in accelerating and improving the quality of wound healing. Its multifaceted action, including enhanced collagen synthesis, robust angiogenesis…
-
BPC 157 Intra-Articular Injections Show Promise for Diverse Knee Pain Conditions
This study provides compelling preclinical evidence that BPC 157, administered directly into the joint, possesses broad regenerative and anti-inflammatory properties capable of addressing multiple forms of knee pain a…
-
BPC 157 Shows Promise for Restoring Blood Flow in Mesenteric Occlusion
This study highlights the significant therapeutic potential of BPC 157 in treating severe vascular occlusive diseases like SMAVO. The ability of BPC 157 to not only reduce tissue damage and inflammation but also to ac…
Research tools
Free, no account — handy when you're working with BPC-157.
